Universal Biosensors Inc (UBI) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.301x

Based on the latest financial reports, Universal Biosensors Inc (UBI) has a cash flow conversion efficiency ratio of -0.301x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.13 Million ≈ $-1.51 Million USD) by net assets (AU$7.08 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Universal Biosensors Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Universal Biosensors Inc - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Universal Biosensors Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Universal Biosensors Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Universal Biosensors Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
8I Holdings Ltd
AU:8IH
-0.057x
MacDonald Mines Exploration Ltd
V:BMK
-0.004x
LM Funding America Inc
NASDAQ:LMFA
-0.181x
Schroder UK Mid Cap Fund PLC
LSE:SCP
0.003x
Colabor Group Inc.
TO:GCL
0.101x
Arkadia Digital Media Tbk PT
JK:DIGI
0.084x
Timah Resources Ltd
AU:TML
0.007x
NIOX Group PLC
LSE:NIOX
0.130x

Annual Cash Flow Conversion Efficiency for Universal Biosensors Inc (2002–2024)

The table below shows the annual cash flow conversion efficiency of Universal Biosensors Inc from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Universal Biosensors Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$17.37 Million
≈ $12.29 Million
AU$-12.30 Million
≈ $-8.70 Million
-0.708x +5.51%
2023-12-31 AU$19.51 Million
≈ $13.80 Million
AU$-14.62 Million
≈ $-10.34 Million
-0.749x -32.99%
2022-12-31 AU$26.09 Million
≈ $18.46 Million
AU$-14.70 Million
≈ $-10.40 Million
-0.563x -57.19%
2021-12-31 AU$27.61 Million
≈ $19.53 Million
AU$-9.90 Million
≈ $-7.00 Million
-0.358x -64.20%
2020-12-31 AU$37.98 Million
≈ $26.87 Million
AU$-8.29 Million
≈ $-5.87 Million
-0.218x -129.81%
2019-12-31 AU$45.39 Million
≈ $32.12 Million
AU$33.24 Million
≈ $23.52 Million
0.732x +2003.00%
2018-12-31 AU$50.67 Million
≈ $35.85 Million
AU$1.76 Million
≈ $1.25 Million
0.035x -94.88%
2017-12-31 AU$12.77 Million
≈ $9.04 Million
AU$8.69 Million
≈ $6.15 Million
0.681x +27.96%
2016-12-31 AU$13.25 Million
≈ $9.38 Million
AU$7.05 Million
≈ $4.99 Million
0.532x +285.32%
2015-12-31 AU$13.26 Million
≈ $9.38 Million
AU$1.83 Million
≈ $1.29 Million
0.138x +150.33%
2014-12-31 AU$19.74 Million
≈ $13.97 Million
AU$-5.41 Million
≈ $-3.83 Million
-0.274x +51.04%
2013-12-31 AU$29.68 Million
≈ $21.00 Million
AU$-16.63 Million
≈ $-11.77 Million
-0.560x -568.20%
2012-12-31 AU$39.37 Million
≈ $27.86 Million
AU$-3.30 Million
≈ $-2.34 Million
-0.084x +58.99%
2011-12-31 AU$35.02 Million
≈ $24.78 Million
AU$-7.16 Million
≈ $-5.07 Million
-0.204x -50.48%
2010-12-31 AU$47.22 Million
≈ $33.41 Million
AU$-6.41 Million
≈ $-4.54 Million
-0.136x -218.81%
2009-12-31 AU$51.31 Million
≈ $36.31 Million
AU$5.87 Million
≈ $4.15 Million
0.114x +177.99%
2008-12-31 AU$48.70 Million
≈ $34.46 Million
AU$-7.14 Million
≈ $-5.05 Million
-0.147x +5.45%
2007-12-31 AU$60.07 Million
≈ $42.51 Million
AU$-9.31 Million
≈ $-6.59 Million
-0.155x -146.03%
2006-12-31 AU$37.05 Million
≈ $26.21 Million
AU$-2.33 Million
≈ $-1.65 Million
-0.063x -209.68%
2005-12-31 AU$3.93 Million
≈ $2.78 Million
AU$226.00K
≈ $159.91K
0.057x +11.37%
2004-12-31 AU$3.97 Million
≈ $2.81 Million
AU$205.00K
≈ $145.05K
0.052x -79.48%
2002-12-31 AU$1.36 Million
≈ $962.29K
AU$342.00K
≈ $241.99K
0.251x --

About Universal Biosensors Inc

AU:UBI Australia Medical Devices
Market Cap
$2.95 Million
AU$4.17 Million AUD
Market Cap Rank
#29486 Global
#1698 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.04
All Time High
AU$1.00
About

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more